ym 529 has been researched along with 1,1-hydroxyoctanodiphosphonate in 1 studies
| Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (1,1-hydroxyoctanodiphosphonate) | Trials (1,1-hydroxyoctanodiphosphonate) | Recent Studies (post-2010) (1,1-hydroxyoctanodiphosphonate) |
|---|---|---|---|---|---|
| 140 | 23 | 71 | 9 | 0 | 1 |
| Protein | Taxonomy | ym 529 (IC50) | 1,1-hydroxyoctanodiphosphonate (IC50) |
|---|---|---|---|
| Geranylgeranyl pyrophosphate synthase | Homo sapiens (human) | 4.3 | |
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | 6.465 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, FG; Chan, JM; Ling, Y; Moreno, SN; Odeh, S; Oldfield, E; Sahota, G | 1 |
1 other study(ies) available for ym 529 and 1,1-hydroxyoctanodiphosphonate
| Article | Year |
|---|---|
Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
Topics: Aldose-Ketose Isomerases; Alkyl and Aryl Transferases; Animals; Antiprotozoal Agents; Cell Line; Diphosphonates; Fosfomycin; Geranyltranstransferase; Humans; Mice; Models, Molecular; Multienzyme Complexes; Oxidoreductases; Quantitative Structure-Activity Relationship; Toxoplasma; Toxoplasmosis | 2005 |